8-K - Viatris Inc (0001792044) (Filer)
Published . Updated .
Key takeaways
- 8-K - Viatris filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
- Exposed: VTRS
- Market reaction: VTRS −0.7% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - Viatris filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
Directly affected
- VTRS Viatris+8.8% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Viatris belongs to, so it often moves with news about it.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and is a peer of Viatris in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson is a peer of Viatris in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+12.0% 30d
AbbVie is a peer of Viatris in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.5% 30d
Merck is a peer of Viatris in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+10.0% 30d
Abbott Laboratories is a peer of Viatris in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| VTRS | +0.60% | -0.27% | base | -0.65% | after close | after close | after close |
| XLV | +0.52% | -0.04% | base | -0.80% | after close | after close | after close |
| LLY | -0.12% | -0.28% | base | -0.81% | after close | after close | after close |
| JNJ | -0.65% | +0.33% | base | -1.55% | after close | after close | after close |
| ABBV | -0.23% | -0.02% | base | -0.79% | after close | after close | after close |
| MRK | +2.39% | +1.67% | base | -0.82% | after close | after close | after close |
| ABT | +2.73% | -0.23% | base | +0.17% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-17 AccNo: 0001140361-26-044356 Size: 203 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Viatris (VTRS) since “8-K - Viatris Inc (0001792044) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -0.79% | still updating |
| ABBV | three days earlier | -0.02% | final price |
| ABBV | five days earlier | -0.23% | final price |
| ABT | that day | +0.17% | still updating |
| ABT | three days earlier | -0.23% | final price |
| ABT | five days earlier | +2.73% | final price |
| JNJ | that day | -1.55% | still updating |
| JNJ | three days earlier | +0.33% | final price |
| JNJ | five days earlier | -0.65% | final price |
| LLY | that day | -0.81% | still updating |
| LLY | three days earlier | -0.28% | final price |
| LLY | five days earlier | -0.12% | final price |
| MRK | that day | -0.82% | still updating |
| MRK | three days earlier | +1.67% | final price |
| MRK | five days earlier | +2.39% | final price |
| Viatris (VTRS) | that day | -0.65% | still updating |
| Viatris (VTRS) | three days earlier | -0.27% | final price |
| Viatris (VTRS) | five days earlier | +0.60% | final price |
| XLV | that day | -0.80% | still updating |
| XLV | three days earlier | -0.04% | final price |
| XLV | five days earlier | +0.52% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 14 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 28 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 48 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 64 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 74 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 90 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 41 days before publication. Filed 5 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Viatris Inc (0001792044) (Filer)”
Companies tied to this story
- VTRS Viatris
For “8-K - Viatris Inc (0001792044) (Filer),” Viatris (VTRS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> VTRS
How “8-K - Viatris Inc (0001792044) (Filer)” reaches Viatris (VTRS)
On 17 Nov 2026, “8-K - Viatris Inc (0001792044) (Filer)” is the story that connects Viatris (VTRS) to this story.
The link for Viatris (VTRS) is this: SEC 8-K filing -> direct issuer disclosure -> VTRS
Price levels for Viatris (VTRS)
VTRS traded between 17.18 and 19.96 across 20 sessions. The latest close on file is 18.97.
How solid “8-K - Viatris Inc (0001792044) (Filer)” looks
14 out of 100Price not final
“8-K - Viatris Inc (0001792044) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company. The price is not final yet.